Predictors of outcome in myxoedema coma: a study from a tertiary care centre

[1]  K. Mann,et al.  Häufigkeit, klinisches Bild und Behandlung des hypothyreoten Komas , 1997, Medizinische Klinik.

[2]  B. Arafah.  Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. , 2006, The Journal of clinical endocrinology and metabolism.

[3]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[4]  B. Turner.  Myxoedema coma. , 2005, Acute medicine.

[5]  A. Fournier,et al.  Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment , 2005, Intensive Care Medicine.

[6]  Joan R. Griffith,et al.  Williams Textbook of Endocrinology, 10th edition , 2004 .

[7]  R. García-mayor,et al.  Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. , 2004, The Journal of endocrinology.

[8]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[9]  A. Fujiyoshi,et al.  Factors associated with mortality of myxedema coma: report of eight cases and literature survey. , 1999, Thyroid : official journal of the American Thyroid Association.

[10]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[11]  K. Mann,et al.  [Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey]. , 1997, Medizinische Klinik.

[12]  R. Jordan.  Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. , 1995, The Medical clinics of North America.

[13]  J. Nicoloff,et al.  Myxedema Coma: A Form of Decompensated Hypothyroidism , 1993 .

[14]  M. Rashkin,et al.  Lithium toxicity and myxedema coma in an elderly woman. , 1990, The Journal of emergency medicine.

[15]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[16]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[17]  U. Rosenqvist,et al.  Treatment of myxoedema coma--factors associated with fatal outcome. , 1985, Acta endocrinologica.

[18]  G. Medeiros-Neto,et al.  Management of myxedema coma: report on three successfully treated cases with nasogastric or intravenous administration of triiodothyronine , 1982, Journal of endocrinological investigation.

[19]  A. Khaleeli.  Myxoedema coma. A report on five successfully treated cases , 1978 .

[20]  W. C. Ball,et al.  Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine. , 1972, Annals of internal medicine.

[21]  J. Hershman,et al.  Absorption of oral thyroxine in hypothyroid and normal man. , 1970, The Journal of clinical endocrinology and metabolism.

[22]  C. J. Goodner,et al.  TREATMENT OF MYXEDEMA COMA WITH INTRAVENOUS THYROXINE. , 1964, Archives of internal medicine.

[23]  C. Forester.  Coma in myxedema. Report of a case and review of the world literature. , 1963, Archives of internal medicine.